Norway
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
2.12%
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
2 |
1.95%
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
3 |
-7.61%
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
4 |
-269.92%
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
5 |
-679.43%
|
Dec. 31, 2023 | USD 0.11 | -0.62% |
|
Norway |
|
6 |
-53,785.59%
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Pharmaceuticals company in Norway with the highest EBT Margin is Navamedic ASA (Oslo Stock Exchange: NAVA.OL) at 2.12%.
The Pharmaceuticals company in Norway with the lowest EBT Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -53,785.59%.
The top 10 Pharmaceuticals companies in Norway by EBT Margin are Navamedic ASA, Photocure ASA, Gentian Diagnostics ASA, Lifecare AS, PCI Biotech Holding ASA and BerGenBio ASA.
The bottom 10 Pharmaceuticals companies in Norway by EBT Margin are BerGenBio ASA, PCI Biotech Holding ASA, Lifecare AS, Gentian Diagnostics ASA, Photocure ASA and Navamedic ASA.